Aztreonam (Azactam - Squibb) is the first monobactam (MONOcyclic BACterially produced β-lacTAM) to be marketed. Monobactams differ from penicillins and cephalosporins in having no ring structure attached to the β-lactam nucleus. Aztreonam is promoted as an alternative to aminoglycosides such as gentamicin.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.